España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
AREV Life Sciences Global
AREVF
OTCPK
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.171000
0.16
1610.00%
Pre-Market: Feb 14, 4:03 PM EDT
Get Report
Comment
AREV Life Sciences Global (AREVF) Forecast
News
Earnings
AREV Life Sciences Global (AREVF) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for AREV Life Sciences Global (OTC:AREVF) Stock
AREV Life Sciences Global Stock (OTC: AREVF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, August 30, 2022
SUSTAINN, AREV's Ready to Use Therapeutic Foods discussed in leading article in HealthHIV
The Newswire
Monday, August 22, 2022
AREV Adds Dr. Apte to the SAB
The Newswire
Saturday, August 20, 2022
AREV Corporate Update
The Newswire
Monday, August 15, 2022
AREV Corporate Update
The Newswire
Monday, June 20, 2022
AREV Life Sciences announces acceleration of the clinical development of SUSTAINN, as further predictions of global famine increase demand for Ready to Use Therapeutic Foods (RUTF)
The Newswire
Wednesday, June 01, 2022
AREV Life Sciences issues retention warrants
The Newswire
Tuesday, April 26, 2022
AREV Life Sciences Global Corporation announces engagement of TransBIOTech to facilitate preclinical therapeutic pipeline development
The Newswire
Sunday, April 24, 2022
Brian V. Elliott Joins Arev Life Sciences Global Corporation
The Newswire
Wednesday, April 13, 2022
Kevin Phelps, CPA Appointed Chief Operating Officer of Arev Life Sciences Global Corporation & Warrant Offering
The Newswire
Wednesday, February 23, 2022
AREV Life Sciences Completes Lab and Fungi Fruiting Room Build
The Newswire
Thursday, February 17, 2022
AREV Life Sciences Advances Developments, New Appointments, and Relationships
The Newswire
Tuesday, January 18, 2022
AREV SAB member Richard Van Breeman PhD publishes landmark study on CoVid19
The Newswire
Friday, December 24, 2021
AREV Life Sciences appoints Allan Echino as Director and Denby Greenslade as interim CFO
The Newswire
Thursday, December 09, 2021
AREV Life Sciences Settles Pending Litigation with Harvey
The Newswire
Thursday, December 02, 2021
AREV Life Sciences / Absolem JV Receives Extraction Results
The Newswire
Tuesday, November 30, 2021
AREV Acquires Wright & Well Essentials Inc.
The Newswire
Monday, November 08, 2021
AREV Life Sciences Global Corp Announces Stock Option Grant
The Newswire
Tuesday, September 07, 2021
AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB REVISED RELEASE first issued July 28, 2021
The Newswire
Thursday, September 02, 2021
AREV Announces Brian Cameron as Chief Financial Officer
The Newswire
Monday, August 09, 2021
AREV Changes their name to AREV Life Sciences Global Corp.
The Newswire
Thursday, July 29, 2021
AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB
The Newswire
Thursday, July 22, 2021
Data Presented at the 11th IAS Conference on HIV Science Supports AREV's Development of SUS-TAINN(TM), a Ready-to-Use Therapeutic Food to Treat Global Malnutrition and Starvation
The Newswire
Tuesday, July 20, 2021
AREV Annual and Special General Meeting Results Appoints Mel Maxwell as an AREV Director
The Newswire
Wednesday, June 16, 2021
AREV Completes Land Survey and Soil Analysis for Cultivation of Mushrooms and Moringa and Prepares for Mass Production of Plant-Based Proteins for Use in Its Ready-To-Use Therapeutic Foods
The Newswire
AREV Completes Land Survey and Soil Analysis for Cultivation of Mushrooms and Moringa and Prepares for Mass Production of Plant-Based Proteins for Use in Its Ready-To-Use Therapeutic Foods
The Newswire
Thursday, June 10, 2021
AREV CEO Michael Withrow Buys 900,000 Shares of Company Stock
The Newswire
Thursday, June 03, 2021
Germinator and AREV Nanotech Brands Inc. Sign Distribution Agreement to Provide the Genesis Platform of Surface Disinfection to Global Public Health Commodity Procurement Programs
The Newswire
Wednesday, June 02, 2021
AREV Engages Dr. Harold C. Smith to Join Scientific Advisory Board
The Newswire
Tuesday, June 01, 2021
AREV Nanotec Brands Inc. Announces Management Cease Trade Order Revoked
The Newswire
AREV Life Sciences Expands its Extraction Results to Clinical Characterization of Compounds, Development of Advanced-Stage Therapeutic Foods and Discovery of Plant-Based Drugs
The Newswire
Friday, May 14, 2021
AREV Nanotec Brands Inc. Provides Management Cease Trade Order Update
The Newswire
Friday, November 15, 2019
Stocks That Hit 52-Week Lows On Friday
Lisa Levin
Monday, August 05, 2019
New 52-Week Lows For Monday Morning
Lisa Levin
Tuesday, July 23, 2019
List of Companies Reaching Yearly Lows Tuesday
Lisa Levin